2464.3000 -22.60 (-0.91%)
NSE Dec 26, 2025 15:31 PM
Volume: 32,764
 

2464.30
-0.91%
Karvy
Revenues for the quarter at Rs 7880 mn were below our estimates of Rs 8195 mn. The operating margins at 21% in Q1FY20 were below our estimates of 23.2% on account of lower revenue traction and lower gross margin.
GlaxoSmithKline has lost -25.37% in the last 6 Months
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended